Physician profile
Gregory Michael Daubs
NPI 1811428758
$8,376.25
in general payments reported to CMS, 2019-2025
8 companies · $1,146 in 2025
The $1,146 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $579 · 2023: $3,753 · 2024: $2,897 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,658 · Food and Beverage: $2,999 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,658.40 |
| Food and Beverage | $2,998.60 |
| Education | $139.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,438.21 | 2022-2025 | Arcos, G7, Persona |
| Stryker Corporation | $2,367.99 | 2022-2025 | Pro, Mako, Gamma |
| Arthrex, INC. | $1,624.01 | 2023 | |
| Goode Surgical INC | $412.14 | 2022-2025 | |
| Polaris Technology Solutions LLC | $282.22 | 2023-2025 | |
| Depuy Synthes Sales INC. | $150.86 | 2023-2025 | Na, Tfn-Advance, Va-Lcp |
| Smith+Nephew, INC. | $61.90 | 2023 | Renasys Go V2 Home, Pico |
| Illuminoss Medical, INC. | $38.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Daubs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.